Reversing the risk factor in babies with early interventions

Research Updates

While we know that the earliest changes of atherosclerosis can begin in children and teenagers, our recent studies, in collaboration with Dr Michael Skilton at The University of Sydney, have shown that the origins of heart disease and vessel disease can begin even earlier – in the foetus.

Those babies born ‘small for dates’, that is in the lowest five per cent of birth weights at term delivery, appear to be at high risk of high blood pressure, diabetes and cardiovascular disease later in life.

Our Clinical Research Group has planned a series of novel intervention studies, mainly with fish oils, to see if we can reverse this risk factor with early intervention.

Tags:

CAPS Clinical Research Fish Oil

Related news

Prof David Celermajer: “Science is our only hope to save the planet”

Professor David Celermajer, Clinical Director at the Heart Research Institute and world debating champion, delivers the Keynote Address at Illuminate 2016.

Meet the team: Kelly Stanton

When HRI researcher Kelly Stanton took three months off her PhD to take part in a humanitarian mission in the Asia Pacific, she didn’t know what to expect. Deployed as the defence force cardiologist on board the USNS Mercy, the only thing Kelly knew was that they were looking for an Australian cardiologist.

Supporting cardiology care across the Pacific

Researcher and cardiologist at the HRI, Dr Kelly Stanton, is taking her skills across the seas to treat patients in East Timor and beyond for cardiovascular conditions.